A former 20-year employee alleges he was fired after repeatedly raising concerns about potential contamination in Boehringer Ingelheim's Cyltezo, a biosimilar version of Humira. The lawsuit seeks damages for retaliation, wrongful termination, and emotional distress.
Multinational pharmaceutical company Boehringer Ingelheim is being sued by a former employee of 20 years who claims he was fired in retaliation for whistleblowing on safety and regulatory concerns related to a drug's development.
In a complaint filed Wednesday in Alameda County Superior Court, Brian Coloma alleges the company repeatedly ignored or suppressed warnings about potential contamination risks to a biosimilar version of the autoimmune drug Humira, marketed as Cyltezo....
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$895, but save $100 when you subscribe today… Just $795 for the first year!
The Department of Justice announced a more than half-billion-dollar settlement with Kaiser Permanente over claims the health care provider submitted false diagnosis codes for Medicare Advantage Pl...